Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents
We recently reported that bacteria can be found within pancreatic ductal adenocarcinoma (PDAC) tumors. Some of these bacteria can metabolize and thereby inactivate the nucleoside analog gemcitabine. We demonstrated that the long isoform of the bacterial enzyme cytidine deaminase (CDD) mediates the m...
Main Authors: | Leore T. Geller, Ravid Straussman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2017.1405139 |
Similar Items
-
Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01) -
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
by: Rozana Abdul Rahman, et al.
Published: (2021-07-01) -
PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
by: Leonardo Mercanti, et al.
Published: (2023-05-01) -
The Role of Nonapoptotic Programmed Cell Death — Ferroptosis, Necroptosis, and Pyroptosis — in Pancreatic Ductal Adenocarcinoma Treatment
by: Sheng-Kai Hsu, et al.
Published: (2022-05-01) -
Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence
by: Ashish Manne, et al.
Published: (2023-04-01)